3D Medicines Inc. (1244.HK)
HKD 3.49
(4.18%)
HKD 3.49
(4.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 634.94 Million | 567.39 Million | 60.26 Million | - |
| Cost of Revenue | 110.93 Million | 42.21 Million | 4.27 Million | - |
| Gross Profit | 524.01 Million | 525.17 Million | 55.98 Million | - |
| Operating Expenses | 585.85 Million | 846.54 Million | 559.06 Million | 303.92 Million |
| Selling, General and Administrative Expenses | 595.88 Million | 500.48 Million | 193.79 Million | 27.57 Million |
| Research and Development Expenses | 425.49 Million | 350.86 Million | 373.7 Million | 263.97 Million |
| Other Expenses | - | -717.17 Million | -957.1 Million | -319.23 Million |
| Cost and Expenses | 1.13 Billion | 888.75 Million | 563.34 Million | 303.92 Million |
| Operating Income | -497.24 Million | -996.46 Million | -1.45 Billion | -627.47 Million |
| Interest Expense | 7.77 Million | 3.11 Million | 1.52 Million | 8.05 Million |
| Income Tax Expense | 55 Thousand | -27.68 Million | -27.73 Million | - |
| Earnings before Tax | -562.46 Million | -1.05 Billion | -1.46 Billion | -635.38 Million |
| Net Income | -524.69 Million | -1.02 Billion | -1.43 Billion | -635.38 Million |
| Earnings Per Share Basic | -2.30 | -22.52 | -36.72 | -13.93 |
| Earnings Per Share Diluted | -2.30 | -22.52 | -36.72 | -13.93 |
| Weighted Average Shares Outstanding | 228.46 Million | 45.48 Million | 39.05 Million | 45.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 228.46 Million | 45.48 Million | 39.05 Million | 45.59 Million |
| Gross Margin | 0.83 | 0.93 | 0.93 | - |
| EBIT Margin | -0.83 | -1.72 | -23.99 | - |
| Profit Margin | -0.83 | -1.81 | -23.80 | - |
| EBITDA | -529.23 Million | -1.02 Billion | -1.44 Billion | -303.34 Million |
| Earnings Before Tax Margin | -0.78 | -1.76 | -24.20 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 103.21 Million | 103.21 Million | 634.94 Million | 141.19 Million | 141.19 Million | 176.27 Million |
| Cost of Revenue | 16.54 Million | 16.54 Million | 49.09 Million | 24.26 Million | 24.26 Million | 31.2 Million |
| Gross Profit | 86.66 Million | 86.66 Million | 585.85 Million | 116.93 Million | 116.93 Million | 145.07 Million |
| Operating Expenses | 121.82 Million | 121.82 Million | 1 Billion | 285.02 Million | 306.49 Million | 242.59 Million |
| Selling, General and Administrative Expenses | 79.17 Million | 79.17 Million | - | 148.07 Million | 148.07 Million | 149.8 Million |
| Research and Development Expenses | 42.64 Million | 42.64 Million | - | 136.94 Million | 136.94 Million | 75.8 Million |
| Other Expenses | - | - | -62.22 Million | - | - | - |
| Cost and Expenses | 138.36 Million | 138.36 Million | 1.05 Billion | 309.28 Million | 330.75 Million | 273.79 Million |
| Operating Income | -35.15 Million | -35.15 Million | -479.63 Million | -168.09 Million | -143.74 Million | -104.88 Million |
| Interest Expense | - | - | 7.77 Million | - | - | - |
| Income Tax Expense | -35.84 Million | -35.84 Million | 55 Thousand | 27.5 Thousand | 27.5 Thousand | -5.85 Million |
| Earnings before Tax | -57.03 Million | -57.03 Million | -562.46 Million | -186.13 Million | -186.13 Million | -95.1 Million |
| Net Income | -51.75 Million | -51.75 Million | -524.69 Million | -173.1 Million | -173.1 Million | -89.24 Million |
| Earnings Per Share Basic | -0.21 | -0.21 | - | -0.75 | -0.75 | -0.40 |
| Earnings Per Share Diluted | -0.21 | -0.21 | - | -0.75 | -0.75 | -0.40 |
| Weighted Average Shares Outstanding | 245.04 Million | 245.04 Million | 228.46 Million | 232.35 Million | 232.35 Million | 224.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 245.04 Million | 245.04 Million | 228.46 Million | 232.35 Million | 232.35 Million | 224.58 Million |
| Gross Margin | 0.84 | 0.84 | 0.92 | 0.83 | 0.83 | 0.82 |
| EBIT Margin | -0.62 | -0.62 | - | -1.01 | -1.01 | -0.58 |
| Profit Margin | -0.50 | -0.50 | -0.83 | -1.23 | -1.23 | -0.51 |
| EBITDA | -63.55 Million | -63.55 Million | - | -142.15 Million | -142.15 Million | -102.54 Million |
| Earnings Before Tax Margin | -0.34 | -0.34 | -0.76 | -1.19 | -1.02 | -0.59 |
0L35
DGICB
CERA
ATL
SWARAJENG
BPAC11